Diligence memo · auto-generated · as of July 2, 2026
Planet Biopharmaceuticals, Inc.
Planet Biopharmaceuticals, Inc. looks fair against its niche peers and is dormant on financing cadence.
Businessfiled
Planet Biopharmaceuticals, Inc. operates in Other Health Care, based in DANBURY.
No verified homepage on file yet — operating evidence is limited to the public record.
Capital & rounds (filed)filed
Planet Biopharmaceuticals, Inc. has raised $1.5M in disclosed capital across 1 recorded round, aggregated from public filings. Its latest round is modeled as Seed (a $1.0M–$4.0M round).
Largest single filing: $1.5M on 2010-08-31.
Most recent recorded round closed around 2010-08-31.
Valuation (modeled)modeled
Provath models Planet Biopharmaceuticals, Inc. at approximately $37M (range $1.3M–$292M). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.
Read: Fair. Modeled value is 0.93× the median modeled value of Seed Other Health Care companies in 2010–2012 (243 peers) — value vs value, same stage and era. Within the normal band (93% of peer median) for its niche.
Financing rhythm & timingmixed
Last raise 15.8 yr ago; this sector typically re-raises about every 14 months.
Only one round on record and long silent — often defunct, acquired, or gone quiet.
Comparablesmixed
Capital scale ranks ahead of 42% of Other Health Care peers (5377 compared).
Modeled value ranks above 63% of those peers.
Closest niche peers: Coolsystems Inc, Device Innovation Group, LLC, Envoy Partners Llc, Kare Partners LLC, CuMed LLC.
Peoplefiled
6 named people on file across officers, directors and signatories.
Risks & flagsmixed
Financing has been silent well beyond sector cadence — possibly defunct, acquired, or paused.
No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.